Closely-held PharmaJet created two scientific advisory boards (SABs) – infectious diseases and oncology – comprised of leading pharmaceutical industry experts in immunology, cancer, research, and policy shaping...
Search results for - PharmaJet
PharmaJet launches Phase 1 trial of Precision Delivery Systems-delivered VEE vaccine
PharmaJet launched a Phase 1 clinical study evaluating a Venezuelan Equine Encephalitis (VEE) DNA vaccine delivered via the company’s needle-free Precision Delivery Systems. The Phase 1 trial, sponsored by PharmaJet and...
PharmaJet launches Nigerian study of Tropis-administered poliovirus vaccine
PharmaJet launched a study in Nigeria to evaluate the intradermal administration of a fractional inactivated poliovirus vaccine (fIPV) using the company’s Tropis ID Needle-free Injection System. Children at 22 urban and...
PharmaJet partner, Scancell, posts positive data from Phase 2 advanced melanoma trial
PharmaJet partner, Scancell, reported positive data from the first phase of a Phase 2 clinical trial evaluating PharmaJet’s needle-free vaccine delivery system for treatment of advanced melanoma. The Phase 2 study’s...
Former Pfizer vaccine president Nanette Cocero joins PharmaJet board
PharmaJet appointed Nanette Cocero, Ph.D., a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background, to the...
PharmaJet Tropis system authorized for 2 nucleic acid vaccines
PharmaJet’s Tropis system is now the exclusive intradermal delivery system for two authorized novel COVID-19 vaccines. They include: The world’s first plasmid DNA COVID-19 vaccine for administration in humans from Zydus...
Marie Mazur appointed chair of PharmaJet board
PharmaJet named Marie Mazur, PharmD, chairwoman of the board, replacing Ron Lowy, who had chaired the board since 2011. “Marie’s experience and leadership will be of great benefit for our company as we are accelerating...
PharmaJet supporting WHO polio eradication in Pakistan
PharmaJet is providing an additional five million syringes to a WHO polio eradication campaign in Pakistan, starting in May 2023. The supplemental immunization activity campaign will be conducted in two phases in the...
PharmaJet names Nathalie Landry as CSO
PharmaJet appointed Nathalie Landry as chief scientific officer to provide strategic leadership and ensure the company’s clinical and scientific programs align with its global commercial expansion. PharmaJet’s pipeline...
PharmaJet to present immune response DNA vaccine data
Closely-held PharmaJet will present results of a comprehensive review of published scientific literature comparing data associated with various DNA vaccine delivery methods at the World Vaccine Congress 2023 on April 5...
